TY  - JOUR 
AU  - Ovejero-Sánchez, María
AU  - Asensio Juárez, Gloria
AU  - González Díaz, Myriam
AU  - Puebla Ibáñez, María Pilar
AU  - Vicente Manzanares, Miguel
AU  - Peláez Lamamie de C. Arroyo, Rafael
AU  - González Sarmiento, Rogelio
AU  - Herrero Hernández, Ana Belén
PY  - 2022
SN  - 1661-6596
UR  - http://hdl.handle.net/10366/164472
AB  - [EN]Ovarian cancer (OC) is one of the most common gynecologic neoplasia and has the highest mortality rate, which is mainly due to late-stage diagnosis and chemotherapy resistance. There is an urgent need to explore new and better therapeutic...
LA  - eng
PB  - MDPI
KW  - Antineiplastic agents
KW  - Ovarian neoplasm
KW  - Cell lines
KW  - Panobinostat
KW  - Microtubules
KW  - Sulfonamides
KW  - Indoles
KW  - Sulfonamides
KW  - Microtubules
KW  - Apoptosis
KW  - Histone Deacetylase Inhibitors
KW  - Ovarian Neoplasms
KW  - Hydroxamic Acids
KW  - Humans
KW  - Cell Line
KW  - Antineoplastic Agents
KW  - Cell Proliferation
TI  - Panobinostat synergistically enhances the cytotoxicity of microtubule destabilizing drugs in ovarian cancer cells
DO  - 10.3390/ijms232113019
T2  - International Journal of Molecular Sciences
VL  - 23
M2  - 13019
ER  -